Global Blood Screening Industry valued approximately USD 1.76 million in 2016 is anticipated to grow with a healthy growth rate of more than 9.7 % over the forecast period 2019-2025.Initiatives by the various organizations and governments increase awareness about donation and screening before transfusion. According to the WHO, approximately 108 million blood donations are collected every year across the globe. About 50% of these blood donations collected from high-income countries which is home to less than 20% of the total population. Hence, rising awareness coupled with the high demand for safe blood create opportunities in emerging countries. Growing numbers of blood donations and blood donors with growing consciousness about preserving donated blood and growing occurrence of transferable illnesses, growing call for donated blood, rise in spending on fitness, technical developments in blood screening, growing alertness for fitness and increasing number of initiatives by many administrations and government associations are a few important issues motivating the development of the global blood screening Industry size. Yet, composite controlling outlines for sanction, shortage of expert manpower, existence of another know-how like digital immunoassay associated with high original investment expenditure and operative costs of testing are the limiting issues for the development of the global blood screening Industry size.
The objective of the study is to define Industry sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the Industry. Additionally, the report shall also incorporate available opportunities in micro Industrys for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
Blood Screening Industry Share and Size by 2019-2025
Blood Screening Market Segmentation:
* Nucleic Acid Test (NAT)
- Transcription-Medication Amplification (TMA)
- Real-Time Polymerase Chain Reaction (PCR)
* Rapid Test
* Western Blot Assay
* Next-Generation Sequencing (NGS)
By Product & Services:
* Reagents & Kits
* Software & Service
By End Use:
* Blood Bank
* North America
- Rest of Europe
- Rest of Asia-Pacific
- Latin America
- Middle East & Africa
Major Market Players in Blood Screening Market are as follows:
F. Hoffmann-La Roche
Bio-Rad Laboratories, Inc.
Orth - Clinical Diagnostics, Inc.
Therm - Fisher Scientific, Inc.
Becton, Dickinson & Company